Dr. Krambeck’s research focuses on the pathogenesis, treatment and prevention of stone disease and the treatment of BPH. Since 2008 Dr. Krambeck has received funding from the National Institute of Health as part of the Mayo Clinic O’Brien Research grant to study renal precursor lesions contributing to kidney stone formation. At Indiana University she continues her close collaboration with Mayo Clinic to continue her pathogenesis research. As a member of the Endourologic Disease focused Group for Excellence (EDGE), Dr. Krambeck also participates in several national research studies analyzing optimal surgical equipment, techniques and protocols for the treatment of stone disease. Dr. Krambeck has also published extensively on the management of stone disease during pregnancy and has worked to improve treatment options for such patients. In the area of BPH, Dr. Krambeck has a special interest in the treatment of enlarged prostates in the setting of myogenic or weakened bladders. Much of her BPH research focuses on the use of Holmium Laser Enucleation of the Prostate (HoLEP) for the treatment of symptomatic lower urinary tract symptoms.
